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Lipid–peptide interactionsEffective antimicrobial peptides (AMPs) distinguish between the host and microbial cells, show selective
antimicrobial activity and exhibit a fast killing mechanism. Although understanding the structure–function
characteristics of AMPs is important, the impact of the peptides on the architecture of membranes with
different lipid compositions is also critical in understanding the molecular mechanism and speciﬁcity of
membrane destabilisation. In this study, the destabilisation of supported lipid bilayers (SLBs) by the AMP
aurein 1.2 was quantitatively analysed by dual polarisation interferometry. The lipid bilayers were formed on
a planar silicon oxynitride chip, and composed of mixed synthetic lipids, or Escherichia coli lipid extract. The
molecular events leading sequentially from peptide adsorption to membrane lysis were examined in real
time by changes in bilayer birefringence (lipid molecular ordering) as a function of membrane-bound
peptide mass. Aurein 1.2 bound weakly without any change in membrane ordering at low peptide
concentration (5 μM), indicating a surface-associated state without signiﬁcant perturbation in membrane
structure. At 10 μM peptide, marked reversible changes in molecular ordering were observed for all
membranes except DMPE/DMPG. However, at 20 μM aurein 1.2, removal of lipid molecules, as determined
by mass loss with a concomitant decrease in birefringence during the association phase, was observed for
DMPC and DMPC/DMPG SLBs, which indicates membrane lysis by aurein. The membrane destabilisation
induced by aurein 1.2 showed cooperativity at a particular peptide/lipid ratio with a critical mass/molecular
ordering value. Furthermore, the extent of membrane lysis for DMPC/DMPG was nearly double that for
DMPC. However, no lysis was observed for DMPC/DMPG/cholesterol, DMPE/DMPG and E. coli SLBs. The
extent of birefringence changes with peptide mass suggested that aurein 1.2 binds to the membrane without
inserting through the bilayer and membrane lysis occurs through detergent-like micellisation above a critical
P/L ratio. Real-time quantitative analysis of the structural properties of membrane organisation has allowed
the membrane destabilisation process to be resolved into multiple steps and provides comprehensive
information to determine the molecular mechanism of aurein 1.2 action.
Crown Copyright © 2010 Published by Elsevier B.V. All rights reserved.1. Introduction
Currently, one of the major challenges facing infectious diseases is
the increased resistance to multiple drugs [1–3]. The search for and
development of new and effective drugs as alternatives to overcome
drug-resistant infections are a serious imperative. Antimicrobial
peptides (AMPs) are widely distributed in nature and are valuable
candidates for the development of effective therapeutics due to their
ability to kill a broad spectrum of bacteria, fungi, virus and cancer cells
[4–6]. AMPs have advantages over common antibiotics due to their
rapid rate of action in killing microbes, lower chance of developingndMolecular Biology, Monash
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10 Published by Elsevier B.V. All riresistance, and eliciting immunoregulatory activity to the infected
cells [7–11]. The effective and fast rate of antimicrobial activity has
been related to their ability to directly destabilise the cell membrane
[12–14]. Identifying the role of AMP structural parameters in
modulating peptide–membrane interactions leading to membrane
destabilisation andmicrobial cell death has been the main focus in the
rational development of AMPs as anti-infective drugs [11,15,16].
However, due to the direct action of AMPs on the cell membrane, the
main challenge is to understand the exact interplay between AMPs
and cell membranes that underpin phospholipid selectivity and
toxicity to cells, particularly in terms of the changes in bilayer
structure.
The secretions of the dorsal gland of amphibians are rich sources of
novel compounds which include AMPs with potent activity targeted
to microbial cells [6,17,18]. The aurein family of peptides is found inghts reserved.
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and comprises a large group of peptides ranging from 13 to 23
residues [17,19]. One speciﬁc peptide, aurein 1.2, is among the most
active peptide against bacteria, fungi and cancer cells [19–22]. It
consists of 13 amino acidswith the sequence GLFDIIKKIAESF-NH2, and
is one of the shortest amphibian peptides so far reported [17]. The
structural properties of aurein 1.2 have been characterised in various
model membrane systems by spectroscopic techniques [23]. Aurein
1.2 is unstructured in aqueous buffer and forms highly amphipathic
α-helical structures in triﬂuoroethanol/water, in dodecylphospho-
choline micelles, and with phosphatidylcholine (PC) vesicles [24].
Aurein 1.2 has also been shown to cause signiﬁcant changes in
membrane structure, inducing large pressure changes in monolayer
mimics of both cancer andmicrobial membranes [20,25]. Perturbation
of membranes by aurein 1.2 is also evident from differential scanning
calorimetry and Fourier transform infrared spectroscopy analysis in
DMPC and DMPG liposomes [26]. Furthermore, the membrane
destruction by aurein 1.2 has also been demonstrated by the release
of a large ﬂuorescence marker, with simultaneous loss of intensity of a
membrane-incorporated ﬂuorescence marker [27]. Various techni-
ques such as surface plasmon resonance (SPR), quartz crystal
microbalance (QCM) and atomic force microscopy (AFM) have been
used to determine the relative afﬁnity and kinetics of aurein binding
on different membrane systems, and have also demonstrated a rapid
disruption of the membrane [28,29], in accord with the ﬂuorescence-
based studies [27]. Based on its membrane-lytic activity, the
‘detergent-like or carpet-like’model has been proposed for the action
of aurein, which is too short to form transmembrane pores. However,
the exact mode of action of this family of peptides is still not
established, although peptide hydrophobicity, hydrophobic moment,
and lipid composition and charge of the target cell membrane all
contribute to the ability of the peptide to perturb the cellular
membrane [11,15]. We propose that a lack of information on the
lipid bilayer properties and the structural and dynamic changes of the
bilayer during peptide interaction can to lead to an over-simpliﬁed
description of the mechanism of AMP action. For example, little is
known about how the surface structure of the membrane and how
speciﬁc features such as molecular packing affect peptide binding
characteristics in real-time. Therefore, a study of concomitant changes
in peptide structure and the structural organisation of lipid bilayer
throughout the sequence of events, from initial electrostatic interac-
tion to the ﬁnal membrane destabilisation, is needed. However,
currently available techniques have limited capacity to monitor and
analyse such molecular rearrangements and order within a lipid
membrane in real time. For example, the non-continuous ﬂow
systems used in QCM and AFM provide the bulk properties in the
former while limited time resolution is obtained by AFM. While SPR
provides binding data in real-time, no information is obtained on the
structure of the membrane during the binding process.
In order to investigate the action of aurein 1.2 on the structural
characteristics of the membrane, we have established a range of
membrane systems on a planar silicon oxynitride chip surface and the
peptide-induced changes in the structure of these membranes were
monitored quantitatively in real time using dual polarisation
interferometry (DPI) technology [30–32]. These planar membrane
systems represent models of both eukaryotic and bacterial mem-
branes. Speciﬁcally, zwitterionic phospholipids such as dimyristoyl-
phosphatidylcholine (DMPC) are widely used to mimic eukaryotic
membranes while the anionic dimyristoylphosphatidylglycerol
(DMPG), being commonly found in bacteria, is used to mimic the
electrical properties of negatively charged bacterial cell membranes.
Moreover, phosphatidyl-ethanolamines (PEs) are major components
of all eukaryotic plasma membranes and are also abundant in Gram-
negative bacteria. Thus, the mixture of dimystoylphosphatidyletha-
nolamine (DMPE) and DMPG was used as membrane models for the
Gram-negative bacteria. Addition of cholesterol to phospholipidbilayers was used as a membrane model for mammalian cells. An
Escherichia coli membrane model was also established using lipids
extracted from E. coli cell membranes.
Together with DPI, the experimental design allows both the
acquisition of kinetic data on bilayer formation via vesicle adsorption
[30] and subsequent analysis of peptide–membrane interaction,
throughout the entire sequence of events involving peptide binding,
insertion and membrane destruction. DPI provides simultaneous
quantiﬁcation of real-time changes in the thickness, mass/density and
birefringence of the membrane. While optical birefringence is a well
known property for aligned bilayer membranes [30,33–36], changes to
such properties during peptide interactions have been less studied
[35,37,38]. Since the birefringence quantiﬁes the degree of alignment
and uniaxial packing of the lipid molecules on the planar surface,
changes in birefringence as a function of peptide binding to the
membrane provide a unique insight into themechanismof binding, and
the rate and concentration dependent changes in lipid packing and
membrane destabilisation. Thus, emphasis can now be placed on
examining the geometric and dynamic arrangements within a lipid
matrix and the functional role of lipidmolecular ordering in peptide and
lipid interactions. Overall, we show that DPI analysis of aurein binding
data correlates well with previous biosensor and spectroscopic studies
and provides new data on the dynamic, geometric changes in
membrane structure leading to a more detailed understanding of the
multiple steps associated with peptide–membrane interactions.
2. Materials and methods
2.1. Chemicals and reagents
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-
dimyristoyl-sn-glycero-3-[phosphor-rac-(1-glycerol)] sodium salt
(DMPG), 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine
(DMPE) and E. coli polar lipid extract (67% phosphatidylethanolamine,
23.2% phosphatidylglycerol and 9.8% cardiolipin) were obtained from
Avanti Polar Lipids (Alabaster, AL). 4-Morpholinepropanesulfonic acid
(MOPS), sodium chloride, calcium chloride, cholesterol (Chl) and
sodium dodecyl sulfate (SDS), all analytical grade, were purchased
from Sigma-Aldrich (St Louis, MI). Chloroform, methanol and ethanol
were all HPLC grade purchased from Merck (Darmstadt, Germany).
Hellmanex II was obtained from Hellma (Müllheim, Germany). Water
was quartz-distilled and deionised in a Milli-Q system equipped with
UV oxidation to remove organic residue (Millipore, Bedford, MA).
Aurein 1.2 was purchased from Mimotopes (Melbourne, Australia).
The purity of peptides was analysed using a capillary reversed phase
C18 column (Zorbax SB 0.5×150 mm, 5 μm, 300 Å, Agilent, St Clara,
CA) with linear gradient elution from 0.1% formic acid-milli Q to 60%
acetonitrile, 0.1% formic acid in 40 min. The peptide mass was further
conﬁrmed by an LC-MSD ESI-ion trap mass spectrometer (Agilent, St
Clara, CA). Peptide concentration was determined by amino acid
analysis.
2.2. Liposome preparation
Stock solutions of individual lipids were prepared in organic
solvent for preparation of dried lipid ﬁlms of varying composition:
2 mM DMPC stock in chloroform, and 2 mM stock each of DMPG,
DMPE and Chl in chloroform/methanol (1:1) where mixed as
appropriate for DMPC, DMPC/DMPG (molar ratio 4:1), DMPE/DMPG
(4:1) and DMPC/DMPG/Chl (16:4:5) ﬁlms. E. coli polar lipid extract
stock was solubilized in chloroform/methanol (1:1) at 1.0 mg/mL.
The stock solutions were aliquoted to the bottom of clean Pyrex test
tubes to give the total lipid amount of 0.8 μmole or 0.8 mg for E. coli
lipids. The organic solvent was then evaporated under a gentle stream
of N2 gas, and vacuum dried overnight to ensure no residual organic
solvent remained. Lipid ﬁlms were hydrated to 1 mM lipid (or 1 mg/
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150 mM NaCl buffer at 37 °C for 1 h with constant vortexing. The
hydrated lipid suspension was then ultrasonicated in a 37 °C water
bath for 30 min. In general, the lipid solution turned clear within
20 min. Clear liposome solutions were extruded through a 50 nm
polycarbonate membrane 21 times using an AVESTIN Liposofast
extruder (Avestin, ON, Canada). The size distribution of resulting
small unilamellar vesicles (SUVs) were characterised with a Malvern
Zetasizer 3000 dynamic light scattering instrument using a 5 mWHe-
Ne laser and Windows PCS version 1.31 software (Malvern Labora-
tories Ltd, Malvern, UK).
2.3. Preparation of unilamellar lipid bilayer on a planar silicon oxynitride
AnaChip
The supported lipid bilayers (SLB) were prepared via in situ
adsorption of liposomes to the planar silicon oxynitride waveguide
chip. This method produces solvent-free lipid bilayers homogenously
spreading on the surface with very few defects. Unmodiﬁed silicon
oxynitride FB80 AnaChips (dimensions 24×6 mm) (Farﬁeld Group,
UK) were clamped inside a dual-zone temperature-controlled
housing. The temperature was controlled with a Peltier systemwithin
0.005 °C. The waveguide chip was clamped with a 100 μm thick
ﬂuorosilicon mask with two slots which provide two separate
microﬂuidic channels over the sensing waveguide. A highly clean
chip surface is a critical step in forming lipid bilayers with
reproducible geometrical structure. The chip surface was in situ
cleaned at 28 or 30 °C with 10% Hellmanex II followed by 2% SDS and
absolute ethanol. After chip cleaning, the chip surface and the bulk
solution were calibrated with respect to their optical properties using
an 80:20 (w/w) ethanol/H2O mixture and water at 20 °C, respec-
tively. The bulk buffer, 10 mM MOPS pH 7.0, 150 mM NaCl, was used
for all experiments. The ﬂow rate of bulk buffer was controlled using
an independent Harvard Apparatus PHD2000 programmable syringe
pump.
In all lipid bilayer experiments, the lipid stock solution was diluted
to 0.1 mg/mL just prior to injection onto the waveguide surface.
Liposomes solutions of DMPC, DMPC/DMPG (4:1), DMPC/DMPG/Chl
(16:4:5), DMPE/DMPG (4:1) and E. coli polar lipid extracts were
injected in the presence of 1 mM CaCl2 for 10 min at 20 μL/min at
28 °C. At the end of the liposome injection, a running buffer containing
1 mM CaCl2 was injected for 10 min to stabilise the SLB. The adsorbed
lipid bilayers were further equilibrated in running buffer for an
additional 20 min until a stable baseline was achieved. The coverage
and defect of SLBswere checkedwith an injection of 50 μL BSA (50 μg/
mL). A complete coverage of lipid bilayer was conﬁrmed by the
absence of BSA binding.
2.4. Peptide binding to the SLBs
Aurein 1.2 was prepared at concentrations of 5, 10 and 20 μM in
running buffer (10 mM MOPS pH 7.0, 150 mM NaCl). For aurein 1.2
binding to the DMPC SLBs, two methods were employed to examine
the effects of accumulated peptide on themembrane. In Method 1, the
chip was cleaned and regenerated with a fresh DMPC SLB between
injections of each peptide concentration. In Method 2, increasing
peptide concentrations were injected sequentially onto the same
DMPC SLBs. For both Method 1 and 2, 180 μL of each peptide
concentration was injected at a ﬂow rate of 40 μL/min, followed by a
30 min equilibrium time. The waveguide surface was regenerated
with 2% SDS, 10% Hellmanex II and ethanol at 28 °C.
2.5. Dual polarisation interferometry
Dual polarisation interferometry is an analytical method for
analysing thin ﬁlms using a dual optical waveguide interferometrictechnique. Alternate dual orthogonal polarisation allows unique
combinations of several opto-geometrical properties including re-
fractive index (RI), density, thickness, mass and birefringence to be
measured in real time for the formation of biomolecule layers.
DPI, as deployed in the Analight BIO200 (Farﬁeld Group Ltd,
Manchester, UK), consists of a dual slab waveguide sensor chip with
an upper sensing waveguide that supports the lipid bilayer, and a
lower optical reference waveguide illuminated with an alternating
polarized laser beam (He-Ne, wavelength 632.8 nm). The sensor chip
comprises four layers of deposited silicon oxynitride on a siliconwafer
surface. Two orthogonal polarizations are passed through the sensor
chip creating two different waveguide modes, namely transverse
electric (TE) and transverse magnetic (TM) waveguide modes. Each
mode generates an evanescent ﬁeld from the top sensing waveguide
surface interactingwithmaterials coming into contact with the sensor
surface and resulting in a change in RI. When this occurs, the phase
difference between the sensing waveguide and the buried reference
waveguide is altered and the position of the interference fringes
changes. In this way the sensor is capable of measuring very subtle
molecular changes that occur on the sensor surface. The interference
fringe pattern for each TM and TE waveguide mode shown as the
diffraction fringe image, illuminates a 1024×1024 element-imaging
device in the far-ﬁeld, the output of which is passed to the digital
signal processing unit. The relative phase position is updated every
2 ms using a spatial Fourier transform method. Two separate
measurements of fringe shift TM and TE data are transferred to
computer for further analysis to provide a real-time data display and
to further resolve the data into thickness and RI values for the growing
layer.
2.6. Calculation of mass for an anisotropic layer
The de Feijter formula [39,40] was employed to calculate the
mass of an adsorbed molecular layer from DPI measurements. The
mass of lipid bilayer (mlipid) formed on the solid support, and the
mass of peptide (mpeptide) bound to the lipid bilayer, are calculated
as follows:
mlipid = df niso− nbufferð Þ= dn=dcð Þlipid; ð1Þ
mpeptide = df niso− nbufferð Þ= dn=dcð Þpeptide; ð2Þ
where df is the thickness of the adlayer and niso denotes the average or
corresponding isotropic RI of the adlayer
niso =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðn2TM + 2n2TEÞ= 3
q
; ð3Þ
nbuffer is the RI of the MOPS buffer used for these experiments, which
was obtained experimentally as nbuffer =1.3349 (T=20 °C) and
1.3340 (T=30 °C); c is concentration, and dn/dc is the speciﬁc
refractive index increment of the adlayer. The de Feijter formula
assumes that dn/dc remains constant throughout the experiment. For
the present analysis, the dn/dc values of 0.135 and 0.182 mL/g were
used for lipids and peptides, respectively [30,39].
2.7. Bilayer birefringence measurement for membrane molecular order
Amongst various types of thin ﬁlms, phospholipid bilayers show
difference in RI for two orthogonal polarisations owing to the liquid
crystal properties of lipid molecules self-assembled into uniaxial
aligned bilayers [33,34,36]. The non-random orientation of lipid
molecules in a membrane creates an anisotropic system with a
uniaxial optical axis with two principal RIs, namely, the extraordinary
RI (ne) which denotes the electric vector polarized parallel to the
optical axis, and the ordinary RI (no) which denotes the electric vector
polarized perpendicular to the optical axis. The difference between
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follows:
Δnf = ne−no ð4Þ
Thus, birefringence can be obtained with DPI through calculating
the difference between two effective refractive indices, namely RI
of transverse magnetic (TM) waveguide mode (nTM) and RI of
transverse electric (TE) waveguide mode (nTE). The degree of
molecular order, S, of the uniaxial lipid bilayer is deﬁned by the
ratio of the principal polarizabilities of the bilayer to the molecular
polarizabilities [33]. This order parameter (S) is proportional to the
birefringence values. Thus, the birefringence values represent an
averaged measurement of lipid molecular orientation order and the
lipid acyl chain order. High Δnf values are obtained for a fully aligned
lipid bilayer whereas low Δnf indicating a random and disordered
lipid bilayer.
The effective birefringence (nTM− nTE) can only be determined by
calculating the two RIs, nTM and nTE, for each waveguide mode by
ﬁxing the thickness or RI of the deposited layer and assuming a
uniform layer coverage. The nTM is affected by the layer thickness and
both ne and no as follows,
nTM =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n2esin
2θ + n2o cos
2θ
q
ð5Þ
where θ, the mode angle, denotes the angle between the optical axis
of the adlayer and the mean path of the two wave mode, while the nTE
is affected only by the layer thickness and no, as
nTE = no ð6Þ
According to Eqs. (5) and (6), both ne and no can be calculated from
nTM and nTE.
The respective effective adlayer nTM and nTE corresponding to the
measured TM and TE phase changes are calculated by ﬁtting the
waveguide equation to the experimental data [30]. When a correct
thickness is used for an anisotropic layer, the difference between the
nTM and nTE will be the true effective birefringence of the adlayer [41].
For deposition of a lipid bilayer, a constant thickness is assumed for
the entire process [30], corresponding to the steric thickness obtained
by neutron scattering and X-ray reﬂectivity. Changes in the RI of the
deposited bilayer can be resolved by ﬁxing the thickness at a
predetermined value of 4.6 nm for all lipids. For the purposes of the
present study, an assumed RI was ﬁxed at 1.47 for the supported lipid
bilayer formation at 20 °C [42,43]. When the RI is ﬁxed for an
anisotropic lipid bilayer, changes in thickness and birefringence,
therefore, density and mass can be further calculated for the
supported lipid bilayer.
3. Results
3.1. Characterisation of SLBs
In order to gain information on the impact of aurein 1.2 on the
structural properties of membranes, establishing a consistent and
quantitatively deﬁnedmembrane structure prior to peptide binding is
critical. The SLBs of different lipid compositions were prepared via in
situ liposome deposition which avoids the inﬂuence of residual
organic solvent on the membrane properties and subsequent peptide
binding. DPI instrumentation has been previously applied to the
detailed analysis of SLB formation with the ability to characterise and
follow intermediate steps involved in the formation of a stable SLB
including kinetics of deposition and deformation of liposomes, the
evolution of birefringence and characterisation of SLB structural
properties [30,37]. The peptide–membrane binding experiment is
therefore divided into four stages: (I) chip and bulk calibration; (II)liposome deposition and SLB formation; (III) peptide binding to the
SLB; and (IV) chip regeneration which removes all bound material.
Based on the experimental parameters determined previously
[37], the SLBs were prepared by depositing 50 nm SUV liposomes at
0.1–0.2 mg/mL at 28 °C in the presence of 1–2 mM Ca2+. Liposome
deposition in the absence of Ca2+ at lower temperatures and higher
lipid concentration resulted in the formation of non-homogeneous
membranes and subsequent analysis of peptide-induced changes in
membrane structure was difﬁcult. Table 1 lists the structural
parameters, RI, density, mass, thickness, birefringence, and surface
area per molecule obtained for ﬁve different membranes, namely
DMPC, DMPC/DMPG (4:1), DMPC/DMPG/Chl (16:4:5), DMPE/DMPG
(4:1) and E. coli (polar lipid extract, PE:PG:CL=67:23.2:9.8 w/w).
Values of the surface area per lipid were obtained from the mass
deposited per unit chip surface area, assuming that a unilamellar
membrane fully covered the whole chip. Highly reproducible and
consistent results were obtained for all SLBs with standard deviations
for bilayer thickness b1.6 Å, except for DMPE/DMPG where a
thickness deviation of 5 Å was obtained. DPI calculations revealed
an average thickness of 45.2±0.7 Å for DMPC. The average
density and mass deposited for the DMPC layers was 0.99±0.01 g/
cm3 and 4.53±0.08 ng/mm2, respectively, with a surface area per
molecule of 49.7±0.9 Å2 at 20 °C. The deposited DMPC/DMPG (4:1)
layer had a higher thickness of 47.6±1.6 Å with density and mass
values of 1.04±0.04 g/cm3 and 4.77±0.16 ng/mm2, respectively,
and a lower surface area/lipid molecule of 47.4±1.6 Å2. These values
are similar to the reported thickness values for DMPC of 46.0±1.5 Å
and DMPC/DMPG (3:1) of 51.7 Å as determined by X-ray reﬂectivity
and neutron reﬂection studies [44].
An important parameter also determined in this study is the
birefringence, which is a measure of molecular ordering or packing of
the SLBs. A higher averaged birefringence value was obtained for the
DMPC/DMPG bilayer compared to the DMPC bilayer, as previously
observed [37]. The small differences in birefringence between the two
lipid compositions is most likely a result of the different ordering and
packing of lipid molecules due to the addition of the negatively
charged DMPG. In addition, the values for a liquid-crystalline DMPC
bilayer at 30 °C were also determined and showed smaller values in
thickness, mass and birefringence with a larger surface area than the
gel phase DMPC. These values are consistent with DMPC molecules
with greatly expanded area and more disorder in the liquid-
crystalline state. With the addition of cholesterol, the mass of SLBs
was signiﬁcantly reduced and the bilayer had lower density and was
less well packed as shown by the lowest birefringence. The adsorbed
DMPE/DMPG bilayer showed the highest birefringence with a
thickness of 43.7 Å and a deposited mass less than the DMPC and
DMPC/DMPG bilayer. These results demonstrated that the smaller
ethanolamine head group of PE associated more strongly with the
phosphate group of adjacent lipids and resulted in higher molecular
order [26]. The geometric parameters obtained for the E. coli polar
extract lipid bilayer showed high values in the adsorbed mass and
thickness with an average birefringence value of 0.0195 which is
lower than that of DMPE/DMPG. The higher mass and thickness of E.
coli SLBs may correspond to a curved membrane at the interface
(‘ripples’) and phase segregation into areas of local high curvature as
observed in a previous QCM-D analysis [45] and maybe due to the
presence of cardiolipin.
3.2. Interaction of aurein 1.2 with DMPC SLBs
3.2.1. Real-time changes in TM, TE, mass and birefringence
The binding of aurein 1.2 to the DMPC SLBs at 20 °C was examined
by two different methods. In Method 1, each concentration of aurein
1.2 was injected onto a freshly prepared DMPC SLB and the real-time
phase changes of the TM and TE waveguide mode for 5, 10 and 20 μM
are shown in Fig. 1A. During the ﬁrst 10 s of the association phase,
Table 1
Physical property values of a unilamellar phospholipid bilayer formed via direct adsorption of small unilamellar vesicles (50 nm SUVs) onto a planar silicon oxynitride Farﬁeld
AnaChip.
Lipid RI⁎ Density (g/cm3)⁎ Thickness (Å)^ Mass (ng/mm2) Birefringence Area/lipid (Å2)
DMPC 1.4677±0.0021 0.99±0.01 45.2±0.7 4.53±0.08 0.0217±0.0006 49.8±0.9
DMPC (30 °C) 1.4685±0.0003 1.00±0.00 42.5±0.0 4.29±0.01 0.0189±0.0003 52.4±0.1
DMPC/DMPG (4:1) 1.4747±0.0046 1.04±0.04 47.6±1.6 4.77±0.16 0.0235±0.0015 47.4±1.6
DMPE/DMPG (4:1) 1.4619±0.0140 0.94±0.10 43.7±5.0 4.34±0.49 0.0244±0.0028 49.5±5.6
DMPC/DMPG/Chl (16:4:5) 1.4372±0.0020 0.76±0.01 34.6±0.6 3.47±0.07 0.0164±0.0003 —
E. coli 1.4707±0.0006 1.01±0.00 58.3±1.3 5.83±0.07 0.0195±0.0020 —
⁎ The isotropic RI and density were calculated using a ﬁxed thickness of 4.6 nm for DMPC and DMPC/DMPG at 20 °C and 4.4 nm for DMPC at 30 °C as determined by neutron
scattering [42,49].
^ The thickness is calculated using a ﬁxed isotropic RI for the lipid ﬁlm of 1.47 [30].
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with the 20 μM peptide resulting in the maximum values. However,
the amount and rate of phase changes deviated from this linear
dependence on peptide concentration indicating that the interaction
involves multiple changes in both peptide and membrane structural
properties which affect the binding behaviour. In particular, a
signiﬁcant decrease in TM and TEwas observed during the association
phase at 20 μM. Analysis of the dissociation phase also revealed
dramatic effects with increasing peptide concentration. At 5 μM, TM
and TE did not return to the pre-injection baseline, indicating that a
percentage of the peptide remained bound to the membrane at the
end of the injection. At 10 μM, TM and TE returned close to the starting
baseline which suggests that all the peptide desorbed from the
membrane surface. However, injection of 20 μM aurein caused TM
and TE values to drop below the starting baseline, suggesting that
material was removed from the surface.Fig. 1. The real-time changes in TM, TE phases (A and B), mass and birefringence (C and D) f
was injected onto a freshly formed DMPC layer (A and C). In contrast, peptide solutions ofThe real-time TM and TE changes were then converted into real-
time changes in mass and birefringence using a ﬁxed lipid RI of 1.47.
As shown in Fig. 1C, the real-time changes in mass for the binding of
aurein 1.2 to DMPC SLBs exhibited similar proﬁles to the TM and TE
changes. In contrast, decreases in birefringence were observed for the
association phase while the birefringence reverted to values close to
an initial value at the end of the dissociation phase. During the
interaction of 5 μM aurein, small amounts of peptide bound to the
DMPC bilayer and induced very small changes in birefringence.
Birefringence remained at a constant value of 0.0220 throughout the
whole process of association and dissociation of the peptide indicating
that there was little to no membrane disordering. At 10 μM, there was
a signiﬁcant increase in membrane-bound aurein 1.2 which was
associated with a large decrease in birefringence. It is interesting to
note that the ﬁnal mass of peptide–membrane complex at the end of
the dissociation was less for 10 μM than for 5 μM, while birefringenceor aurein 1.2 binding to planar unilamellar DMPC SLBs. Each concentration of aurein 1.2
5, 10 and 20 μM were injected consecutively onto the same DMPC SLBs (B and D).
1982 T.-H. Lee et al. / Biochimica et Biophysica Acta 1798 (2010) 1977–1986returned to the starting condition. At 20 μM, a very signiﬁcant change
was observed during the association phase, in which an initial
increase in mass was followed by an abrupt decrease in mass and
which was associated with a further decrease in birefringence. At the
end of the injection, the birefringence then returned to the starting
value but with less mass deposited on the chip. The sharp drop in the
overall mass below that of the starting DMPC layer indicates loss of
membrane material from the chip surface. This rapid association
followed by mass loss for aurein 1.2 binding to DMPC is consistent
with the response proﬁles obtained by SPR analysis [29]. However,
what the DPI analysis now reveals is that the membrane lipids
remaining on the chip surface were able to reorganise into an ordered
layer with similar properties to that of the original DMPC layer.
The binding of aurein to DMPC SLBswas also examined by a second
method (Method 2) in which consecutive injections of 5, 10 and
20 μM aurein were deposited onto the same lipid layer, with each
concentration injected over 4.5 min and allowed to equilibrate with
buffer running over the chip for a total of 30 min prior to the
subsequent injection of the next peptide concentration. This method
was used to evaluate the dynamic changes in bilayer properties
during the build-up of the peptide-lipid complex. The results for the
real-time changes in TM and TE (Fig. 1B) and mass and birefringence
(Fig. 1D) for aurein 1.2 accumulated onto DMPC SLBs are shown in
Fig. 1. At the lower concentration of 5 μM aurein, the DMPC layer
exhibited only a small increase in TM, TE and mass and corresponded
to a small decrease in birefringence, which reverted to 0.022 during
the dissociation phase. These results are similar to those obtained by
Method 1 as the 5 μM injection in both methods occurs on a freshly
formed DMPC bilayer. When the concentration increased to 10 μM,
the phase change in the TM and TE response during peptide
association was nearly double that observed at 5 μM. In addition, at
10 μM, the bilayer birefringence decreased to 0.0204 indicating that
lipid molecules within the layer began to undergo a signiﬁcant
disordering. However, the disorder was not permanent and lipid
molecules repacked and re-ordered during peptide dissociation as the
birefringence increased to close to the original value. Overall at 10 μM,
aurein was not tightly bound to the lipid surface as there was a steep
drop in mass during peptide dissociation, with a similar increment in
mass change in the lipid layer as observed at 5 μM. This overall
increment in layer mass was not seen using Method 1, indicating that
the residual amount of aurein remaining on the bilayer from the 5 μM
injection promotes a higher level of peptide binding if the same
surface is used for higher peptide concentrations. At 20 μM aurein 1.2,
a similar drop in TM, TE and mass was observed during injection as in
Method 1 and the overall real-time change in birefringence was also
similar to Method 1.Fig. 2. The effect of aurein 1.2 binding on themolecular order of DMPC SLBs as a function of m
onto freshly formed DMPC SLBs. (B) Aurein 1.2 was injected accumulatively onto the same3.2.2. Membrane destabilisation as a function of membrane-bound
peptide mass
In addition to the real-time changes in bilayer properties induced
by the peptide, the impact on the molecular order of the bilayer was
also examined by the changes in birefringence as a function of peptide
mass bound to the bilayers [37]. This provides another practical
method to quantify the extent of membrane changes in addition to
the real-time behaviour of peptide–membrane interactions as
presented above. The changes in DMPC birefringence with the
amount of bound aurein 1.2 using Methods 1 and 2 are shown in
Fig. 2A and B, respectively. At 5 μM, a small increase in mass was
observed without changes in birefringence, indicating no change in
bilayer ordering. As peptide concentration increased to 10 μM, a linear
decrease in birefringence with increasing peptide mass was observed
for aurein binding to freshly formed DMPC SLBs (Fig. 2A). During the
initial association of 20 μM aurein, a linear decrease in birefringence
with increasing mass was observed up to a critical threshold
whereupon an abrupt mass decrease occurred at a peptide/lipid
ratio (P/L) of 1:7.5 for a single DMPC bilayer. However, if only the
outer leaﬂet is considered for binding, a P/L of 1:3.8 was reached.
Thus, the lipid surface area for one peptide would be ~186.5 Å2 at the
point where membrane lysis occurred.
In contrast, a curvilinear shape was observed for the plots of
birefringence versus peptide mass for the injection of 10 μM aurein by
Method 2, i.e. consecutive addition to the aurein-DMPC complex
(Fig. 2B). At 20 μM, a small decrease in birefringence with increased
mass was initially observed which was similar to the 10 μM result.
However, as more peptide bound to the DMPC, a second phase of
birefringence decrease with mass increase occurred up to a threshold,
followed by an abrupt loss in mass. This threshold point corresponds
to a P/L ratio of 1:10.6, or 1:5.3 for one leaﬂet of the bilayer, which
corresponds to a surface area of 262.4 Å2 per peptide for membrane
lysis. The non-linear drop in birefringence with increases in peptide
mass obtained with Method 2 is different from the linear changes
observed using Method 1. Thus, the changes in membrane structure
induced by the subsequently injected peptide are not linearly related
to the amount of peptide already bound, suggesting a multi-phase
binding mechanism with regards to the extent and rate of membrane
disordering during peptide binding.
3.3. Inﬂuence of temperature on aurein 1.2 binding to DMPC membranes
The binding of aurein to DMPC SLBs was further examined by
Method 2 at 30 °C, where the DMPC membrane is known to be liquid
crystalline. The real-time changes in mass and birefringence are
shown in Fig. 3A. At 5 μM, only a small amount of aurein bound to theembrane-bound peptidemass. (A) Aurein 1.2 at 5, 10 and 20 μMwas injected separately
DMPC SLB. The temperature was kept at 20 °C.
Fig. 3. The dependence of molecular order of DMPC SLBs on themass of aurein 1.2 binding to DMPC at 30 °C: (A) real-time changes inmass and birefringence, and (B) plot of mass vs.
birefringence plot.
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were evident. In contrast, a signiﬁcant increase in mass was observed
during the association phase for 10 μM aurein, accompanied by a
decrease in birefringence. However, the overall amount of aurein
retained on the DMPC at the end of binding (60 min) was much less
than that obtained at 20 °C. At 20 μM, binding characteristics were
similar to that obtained at 20 °C. The binding showed a fast initial
association followed by an abrupt decrease in mass at a critical
threshold. The overall mass then dropped below the initial bilayer
mass obtained at 0 min. In contrast to 20 °C, the birefringence initially
decreased rapidly, while at the end of peptide injection, the
birefringence reverted back to a value higher than that of the initial
bilayer birefringence.
The dependence of bilayer birefringence on the mass of mem-
brane-bound peptides binding to liquid-crystalline DMPC is shown in
Fig. 3B. There was no change in birefringence with a small amount of
DMPC-bound aurein at 5 μM. Α two phase association was apparent at
10 μM, in which an initial increase in mass with no changes in
birefringence was followed by a linear increase in mass with a
decrease in birefringence. While the extent of changes in birefrin-
gence at 10 μM was much larger than those observed at 20 °C, the
birefringence returned close to the initial high value at the end of the
peptide dissociation. Addition of 20 μM aurein 1.2 to the same DMPC
bilayer caused an initial biphasic binding followed by an abrupt mass
decrease similar to that of 10 μM. However, the critical point at which
the birefringence coincided with a loss in mass occurred at a P/L of
1:4.5 for a unilamellar DMPC bilayer, which corresponds to a lipid
surface area of 118.0 Å2 per peptide. This value is much less than that
obtained for the gel DMPC at 20 °C, which indicates that a higher
amount of aurein is required to disrupt the DMPC bilayer at 30 °C.
3.4. Aurein 1.2 binding to anionic and E. coli membrane SLBs
The effects of aurein 1.2 on negatively charged membranes were
evaluated with SLBs composed of DMPC/DMPG (4:1), DMPC/DMPG/
Chl (16:4:5), DMPE/DMPG (4:1) and E. coli polar lipid extract using
Method 2. The dependence of bilayer birefringence on the mass of
bound aurein for these different SLBs is shown in Fig. 4. For DMPC/
DMPG, the plot showed a similar proﬁle to that of DMPC in which
small changes were observed at low peptide concentration. A loss of
membrane material from the solid support was found at a critical
threshold after injecting 20 μM aurein as shown in Fig. 4A. The P/L at
the point of lipid loss was 1:9.8 and was very similar to that obtained
above for DMPC. However, the overall loss in mass for DMPC/DMPG
from the substrate was nearly double that of DMPC. The DMPC/DMPG
membrane also exhibited reversible birefringence changes, even after
the mass loss, with the DMPC/DMPG molecules reorganised to a
molecular order similar to the starting bilayer prior to peptideinjection. The addition of cholesterol to DMPC/DMPG resulted in a
higher amount of aurein bound to themembranes as shown in Fig. 4B.
The extent of the decreases in birefringence during peptide binding
was also proportional to peptide concentration. Binding to cholester-
ol-containing membranes was reversible in both peptide mass and
bilayer birefringence. However, there was no loss of material during
the binding and there was a drop in birefringence without a change in
mass, which was not seen for other SLBs. These changes indicated that
cholesterol not only changes the packing of the membrane but also
stabilises the membrane against the lytic effect of aurein.
The dependence of bilayer birefringence on bound peptide mass
for DMPE/DMPG is shown in Fig. 4C. Only a small amount of aurein
bound to the membrane and the binding was reversible with no
peptide remaining after the dissociation and there was no evidence of
membrane lysis. Although the negative charge on DMPE/DMPG is
similar to that on DMPC/DMPG bilayers, the low level of binding
suggests that electrostatic interactions may not play a major role in
aurein binding to DMPE/DMPG. The properties of zwitterionic lipid
head groups can affect the packing properties through the interaction
between the positively charged head groups and the negative
phosphate group. These differences in membrane packing (ordering)
may therefore play a major role in the selectivity of aurein towards
PC/PG-containing bilayers. The low binding is also consistent with the
minimal effect of aurein 1.2 on the temperature and enthalpy of the
main phase of zwitterionic DMPE bilayers previously observed during
the binding of aurein [26] at the gel temperature. In contrast, the
binding of aurein to E. coli lipid SLBs showed a large decrease in
birefringence with increasing mass at higher peptide concentration as
shown in Fig. 4D. However, there was again no evidence of membrane
lysis. These large changes in binding characteristics may relate to the
presence of the larger and highly hydrophobic cardiolipin lipids.
However, the large changes in both mass and birefringence for aurein
binding to E. coli were reversible. Hence, the adsorption and
destabilisation of membranes by aurein is strongly inﬂuenced by the
membrane composition, which affect the physical properties such as
the surface electrostatic properties, thickness, density and lipid
ordering.
4. Discussion
Aurein 1.2 is one of the shortest peptides that exhibit antibacterial
and anticancer activity. Analysis of the relationship between the
interaction of aurein with model membranes and the extent of
peptide-induced membrane structure perturbation in real time
provides a new approach to delineating the mechanism of AMP
action. The selective activity of AMPs towards speciﬁc cells indicates
that the physicochemical properties of membranes are central in
determining the molecular mechanism. We have characterised the
Fig. 4. Changes in the molecular order (birefringence) of SLBs as a function of membrane-bound peptide mass obtained at 20 °C: (A) DMPC/DMPG (4:1), (B) DMPC/DMPG/Chl
(16:4:5), (C) DMPE/DMPG (4:1), and (D) E. coli polar lipid extract.
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terised bilayers with deﬁned thickness and molecular order. Produc-
tion of consistent and reproducible SLBs provides a foundation for the
analysis of subsequent peptide binding events. Real-time binding data
was then acquired revealing a process of membrane destabilisation
induced by aurein 1.2 in SLBs. Moreover, these important new insights
are underpinned by the ability to monitor multiple property changes
in the membrane structure.
In the present study, the surface association of aurein 1.2 with all
membranes caused changes in the anisotropic packing characteristics
of lipid head groups and acyl chains. An overview of all the results
reveals signiﬁcant differences in the membrane changes for each of
the ﬁve different membrane mixtures. The interaction of aurein 1.2
with DMPC and DMPC/DMPG produced small changes in membrane
structure even at low peptide concentrations and large increases in
disorder at high peptide concentration. These results are consistent
with the drop in the order parameter by deuteriumNMR as previously
seen for aurein in multilamellar liposomes and aligned DMPC bilayers
P/L 1:10 [24,30,46] and therefore represent the partitioning of aurein
into the hydrocarbon-water interface of the membrane bilayer [26].
This is further supported by the perturbation of the thermotropic
phase behaviour upon aurein incorporation into DMPC and DMPG
MLVs as determined by NMR [29,30]. This birefringence versus mass
proﬁle for aurein was in contrast to the corresponding data we
reported previously for two peptides which insert and remain in the
membrane bilayer, whereby the birefringence decreased with peptide
binding and remained low [37]. Thus for a given amount of
membrane-bound peptide, the extent of membrane disorder (i.e.
drop in birefringence) is smaller for a peptide which binds only to the
membrane surface compared to a peptide which inserts into the
membrane. Therefore, the extent of birefringence changes can be used
to distinguish between surface association and insertion.Aurein has been previously shown to cause membrane lysis [30]
and this was also apparent from the removal of DMPC and DMPC/
DMPGmembrane during peptide injection. It is signiﬁcant to note that
lysis did not occur at the lower concentrations but required a critical
surface coverage as proposed for a detergent-like mechanism of
action [30]. The critical P/L values for lysis obtained in this work for
DMPC and DMPC/DMPG bilayers were also higher than the values
previously observed with liposome disruption in solution [30]. Most
studies adjust the P/L until an abrupt change in liposome integrity is
measured thereby measuring the P/L ratio in solution rather than the
P/L of bound peptide. Thus, the continuous monitoring of membrane
order per membrane-bound peptide provides a more accurate P/L
ratio. Cholesterol is known to have important effects on membrane
structure and stability and in this study, the addition of cholesterol to
the DMPC/DMPG mixture prevented any signiﬁcant lysis of the
membrane by aurein. The birefringence value for the DMPC/DMPG/
Chl bilayer was less than the value for DMPC/DMPG indicating that
the presence of cholesterol has changed the alignment of the acyl
chains. While further studies are needed to determine the effect of
cholesterol on bilayer stability, it is clear that bilayer structure has
affected the ability of aurein to penetrate and disrupt bilayer integrity.
In contrast to the effects on DMPC and DMPC/DMPG bilayers,
aurein showed little binding to and disruption of DMPE/DMPG
bilayers and bound much less than to DMPC/DMPG, even though the
molar percentage of anionic DMPG was the same in both membranes.
Although electrostatic interaction is a common feature of most
cationic AMP activity, and is important for the initial binding of
AMPs, the role of other membrane properties in mediating binding
has been less studied. Aurein is highly helical in membrane
environments [30] and, similar peptide properties would therefore
be expected to contribute to its binding to different membranes. Thus,
the weak binding of aurein to the negatively charged DMPE/DMPG
Fig. 5. Summary of changes in birefringence as a function of peptide mass bound to the
SLBs. (A) The mass derived from the TM and TE phase changes represent the amount of
aurein 1.2 deposited onto the lipid. The binding behaviour involves several proﬁles: (1)
very small changes in birefringence with increase in mass for a surface binding event;
(2) surface association whereby progressive recruitment of peptides induces
membrane disordering; (3) peptide partitioning into the membrane with disordering
almost linearly related to the increase in mass; and (4) membrane lysis resulting in the
removal of mass and loss of membrane. (B) Schematic illustration of the molecular
events corresponding to each proﬁle of the birefringence changes as a function of
membrane-bound peptide mass.
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between DMPE and DMPC. DMPE/DMPG is highly ordered due to the
stronger interaction of ethanolamine with the phosphate moiety in
comparison to the larger choline moiety, and is reﬂected by the fact
that it exhibited the highest birefringence of all membranes in this
study. The combined effect of the stronger interaction between lipid
head groups and the highly packed lipid molecules therefore limited
the binding of aurein to DMPE/DMPG. The limited ability of aurein to
bind to more ordered membranes is also supported by its lower
binding to DMPC in the gel phase (20 °C) compared to the liquid-
crystalline (30 °C) phase.
In contrast, aurein 1.2 bound strongly to E. coli polar lipid SLBs but
did not induce any membrane lysis. The physical properties of
cardiolipin clearly play an important role in the membrane. The
helical aurein is highly amphipathic and this provides the peptide
with a large hydrophobic surface for membrane binding. However,
binding is accompanied by a large degree of peptide dissociation from
the membrane, which is in contrast to peptide inserting into
membrane where very small dissociation was observed. A curved or
‘rippled’ structure for peptide-adsorbed E. coli lipid bilayers may
increase the amount of bound aurein and result in greater membrane
disorder. However, due to the high percentage of PE in the E. coli polar
lipid extract, the ability of aurein to partition into the bilayer
hydrophobic region is limited and the peptide is retained mainly at
the membrane interface and the membrane-bound peptide dissoci-
ated almost completely from the E. coli SLBs.
5. Model of the impact of aurein 1.2 on membrane lipid order
The DPI method used in this work has allowed the accumulated
impact of aurein to effect progressive changes in membrane structure
to be evaluated. The birefringence analysis in this study provides
novel information on the impact of peptides on the changes in
organisation occurring within a lipid bilayer, and assists in describing
the behaviour of an AMP when interacting with a lipid membrane. In
summary, four different transitions can be described based on the
birefringence vs. mass plots (as illustrated in Fig. 5A) which can be
used to evaluate peptide behaviour and AMP mechanism of action.
The molecular events corresponding to these four transitions are
schematically drawn in Fig. 5B and are summarised as:
(1) a near horizontal plot with minimal or no change in
birefringence is representative of surface association of aurein
(Line 1, Fig. 5A). This suggests that peptides bind to the surface
with little to no effect on the order of lipidmolecules within the
membrane (Line 1, Fig. 5B).
(2) a curved plot in which birefringence decreases at different rates
during peptide association, and describes the initial surface
association of aurein (Line 2, Fig. 5A). This is followed by
progressive accumulation of peptide on the surface causing
partial insertion or sinking of aurein and, therefore, increases
the amount of membrane disorder (Line 2, Fig. 5B). An initial
small and slow decrease followed by a large and rapid decrease
in birefringence may be related to a change in the number of
lipid molecules involved in the binding process.
(3) a more rapidly decreasing curved plot whereby birefringence
decreases at a constant rate representing the partition of aurein
deeper into the lipid membrane. Such a rapid decrease in
birefringence with higher amounts of peptide may suggest that
the peptide either fully or partially inserts into the membrane
resulting in a signiﬁcant amount of membrane disordering as
depicted in line 3, Fig. 5B.
(4) the plot changes direction so that both mass and birefringence
decrease, representing the destabilisation and removal of
material from the lipid bilayer (Line 4, Fig. 5). Such behaviour
reﬂects the ability of peptides to initiate membrane lysis by amicelle or detergent-like mechanism (Line 4, Fig. 5B). In
addition, the turning point of the plot can be used to determine
the critical P/L ratio required to initiate membrane lysis.
Overall, transitions 1, 2 and 3 in Fig. 5 are reversible during peptide
dissociation. However, such behaviour is dependent on the peptide
afﬁnity and rate of association with the lipid membrane, In addition,
the number of peptide molecules removed from the layer will
determine the value to which mass and birefringence return during
peptide dissociation. On the other hand, transition 4 is irreversible.
Once the membrane has been lysed and material removed from the
layer, the plot will not return back to the same values as mass and
lipid order have been permanently altered. Thus, the extent of
membrane disorder and the amount of bound peptide as determined
by DPI analysis can help delineate the mechanism of membrane-
active peptides. Other membrane morphology changes are also
possible as recently reported for temporins B and L which induced
the formation of tubular lipid protrusions [14,47]. However, our
previous studies with amphibian peptides have not provided any
evidence of such behaviour [26,27,29,48]. Moreover, the lipid
protrusions reported were several microns long, while the thickness
values determined by DPI analysis in this study did not reﬂect
signiﬁcant changes in thickness prior to lysis by aurein 1.2.
1986 T.-H. Lee et al. / Biochimica et Biophysica Acta 1798 (2010) 1977–1986In conclusion, this study has demonstrated that the sequential
perturbation in membrane from the point of initial peptide–
membrane binding to induced membrane lysis can be determined
by rate and afﬁnity of peptide binding, peptide-to-lipid (P/L) ratio and
the extent and rate of membrane disordering. Analysis of these
properties for a broader range of peptides and with different lipid
membranes will expand our understanding of the relative importance
of these determinants in the control of the various stages of peptide-
induced membrane changes and the critical threshold of membrane
lysis.
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